203 related articles for article (PubMed ID: 35675522)
1. ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent.
Luchtel RA; Zhao Y; Aggarwal RK; Pradhan K; Maqbool SB
Blood Adv; 2022 Oct; 6(20):5613-5624. PubMed ID: 35675522
[TBL] [Abstract][Full Text] [Related]
2. Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
Sakihama S; Morichika K; Saito R; Miyara M; Miyagi T; Hayashi M; Uchihara J; Tomoyose T; Ohshiro K; Nakayama S; Nakachi S; Morishima S; Sakai K; Nishio K; Masuzaki H; Fukushima T; Karube K
Cancer Sci; 2021 Mar; 112(3):1300-1309. PubMed ID: 33426772
[TBL] [Abstract][Full Text] [Related]
3. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.
Shah UA; Chung EY; Giricz O; Pradhan K; Kataoka K; Gordon-Mitchell S; Bhagat TD; Mai Y; Wei Y; Ishida E; Choudhary GS; Joseph A; Rice R; Gitego N; Parrish C; Bartenstein M; Goel S; Mantzaris I; Shastri A; Derman O; Binder A; Gritsman K; Kornblum N; Braunschweig I; Bhagat C; Hall J; Graber A; Ratner L; Wang Y; Ogawa S; Verma A; Ye BH; Janakiram M
Blood; 2018 Oct; 132(14):1507-1518. PubMed ID: 30104217
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Study of the Immunophenotype and its Clinicopathologic Significance in Adult T-Cell Leukemia/Lymphoma.
Tamaki T; Karube K; Sakihama S; Tsuruta Y; Awazawa R; Hayashi M; Nakada N; Matsumoto H; Yagi N; Ohshiro K; Nakazato I; Kitamura S; Nishi Y; Miyagi T; Yamaguchi S; Nakachi S; Morishima S; Masuzaki H; Takahashi K; Fukushima T; Wada N
Mod Pathol; 2023 Aug; 36(8):100169. PubMed ID: 36997002
[TBL] [Abstract][Full Text] [Related]
5. CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
Yoshida N; Miyoshi H; Kato T; Sakata-Yanagimoto M; Niino D; Taniguchi H; Moriuchi Y; Miyahara M; Kurita D; Sasaki Y; Shimono J; Kawamoto K; Utsunomiya A; Imaizumi Y; Seto M; Ohshima K
J Pathol; 2016 Apr; 238(5):621-6. PubMed ID: 26847489
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human T-cell leukemia virus type 1 antisense promoter by myocyte enhancer factor-2C in the context of adult T-cell leukemia and lymphoma.
Madugula KK; Joseph J; DeMarino C; Ginwala R; Teixeira V; Khan ZK; Sales D; Wilson S; Kashanchi F; Rushing AW; Lemasson I; Harhaj EW; Janakiram M; Ye BH; Jain P
Haematologica; 2022 Dec; 107(12):2928-2943. PubMed ID: 35615924
[TBL] [Abstract][Full Text] [Related]
7. Molecular insight into the study of adult T-cell leukemia/lymphoma (ATLL): Ten-year studies on HTLV-1 associated diseases in an endemic region.
Ashrafi F; Rahimzada M; Parandi M; Mirhosseini A; Mashkani B; Ahmadi Ghezeldasht S; Soltani A; Rafatpanah H; Mosavat A; Abdolrahim Rezaee S
Gene; 2022 Dec; 847():146885. PubMed ID: 36108787
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma.
Rauch DA; Olson SL; Harding JC; Sundaramoorthi H; Kim Y; Zhou T; MacLeod AR; Challen G; Ratner L
Retrovirology; 2020 Aug; 17(1):27. PubMed ID: 32859220
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
[TBL] [Abstract][Full Text] [Related]
10. Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.
Nakagawa M; Schmitz R; Xiao W; Goldman CK; Xu W; Yang Y; Yu X; Waldmann TA; Staudt LM
J Exp Med; 2014 Dec; 211(13):2497-505. PubMed ID: 25488980
[TBL] [Abstract][Full Text] [Related]
11. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.
Nakagawa M; Shaffer AL; Ceribelli M; Zhang M; Wright G; Huang DW; Xiao W; Powell J; Petrus MN; Yang Y; Phelan JD; Kohlhammer H; Dubois SP; Yoo HM; Bachy E; Webster DE; Yang Y; Xu W; Yu X; Zhao H; Bryant BR; Shimono J; Ishio T; Maeda M; Green PL; Waldmann TA; Staudt LM
Cancer Cell; 2018 Aug; 34(2):286-297.e10. PubMed ID: 30057145
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
14. Small RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Study.
Pessôa R; de Souza DRV; Nukui Y; Pereira J; Fernandes LA; Marcusso RN; de Oliveira ACP; Casseb J; da Silva Duarte AJ; Sanabani SS
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445821
[TBL] [Abstract][Full Text] [Related]
15. Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American Adult T-Cell Leukemia/Lymphoma cohort.
Zhang X; Shi Y; Ramesh KH; Naeem R; Wang Y
Int J Lab Hematol; 2021 Aug; 43(4):651-657. PubMed ID: 33988304
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.
Shah UA; Shah N; Qiao B; Acuna-Villaorduna A; Pradhan K; Adrianzen Herrera D; Sica RA; Shastri A; Mantzaris I; Derman O; Kornblum N; Braunschweig I; Ye BH; Verma A; Janakiram M
Cancer; 2020 Feb; 126(3):567-574. PubMed ID: 31769871
[TBL] [Abstract][Full Text] [Related]
17. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1.
Bosselut R; Duvall JF; Gégonne A; Bailly M; Hémar A; Brady J; Ghysdael J
EMBO J; 1990 Oct; 9(10):3137-44. PubMed ID: 2209540
[TBL] [Abstract][Full Text] [Related]
18. [The microenvironment and immune status of peripheral T-cell lymphoma: focusing on AITL and ATLL].
Ohshima K; Miyoshi H; Yamada K
Rinsho Ketsueki; 2018; 59(5):574-587. PubMed ID: 29877249
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.
Ishida T; Utsunomiya A; Iida S; Inagaki H; Takatsuka Y; Kusumoto S; Takeuchi G; Shimizu S; Ito M; Komatsu H; Wakita A; Eimoto T; Matsushima K; Ueda R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3625-34. PubMed ID: 14506150
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of parathyroid hormone-related protein promoter P3 by ETS-1 in adult T-cell leukemia/lymphoma.
Richard V; Nadella MV; Green PL; Lairmore MD; Feuer G; Foley JG; Rosol TJ
Leukemia; 2005 Jul; 19(7):1175-83. PubMed ID: 15889157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
